Evaluates memantine's impact on clinical outcomes in Parkinson’s disease, suggesting potential benefits.
To evaluate the efficacy of memantine in improving clinical outcomes in patients with Parkinson’s disease (PD).
No takes yet. Share an insight, caveat, or question.
Sajeendran et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: